$ABMC INSIDERS (% is a WOW).....
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
As of July 24, 2020 there were 35,953,476 common shares outstanding. The following table sets forth, as of July 24, 2020, the beneficial ownership of the Company's common shares by (i) each director, (ii) each nominee for director, (iii) the Named Executive Officer, (iv) all directors and executive officers of the Company as a group, and (v) each shareholder, known to management of the Company, to beneficially own more than five percent (5%) of the outstanding common shares.
The number and percentage of shares beneficially owned is determined under the rules of the United States Securities and Exchange Commission (“SEC”), and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares which the individual has the right to acquire within sixty (60) days after July 24, 2020 through the exercise of any stock option, exchange of exchangeable shares or other right. Unless otherwise indicated, each person has sole voting and investment power (or shares such powers with his or her spouse) with respect to the shares shown as beneficially owned. Unless otherwise noted, the address of each person is c/o American Bio Medica Corporation, 122 Smith Road, Kinderhook, New York 12106.
Title of Class
Name and Address
of Beneficial Owner
Amount and Nature
of Beneficial Ownership
Percent of Class
Common
Chaim Davis
3,309,047(1)
9.18%
Common
Melissa A. Waterhouse
1,250,000(2)
3.36%
Common
Jean Neff
186,226(3)
*
Common
Peter Jerome
120,610(4)
*
Common
Directors and Executive Officers as a group (5 persons)
4,865,883(5)
12.99%
Common
MP Biomedicals LLC
4,738,601(6)
13.18%
Common
John J. Moroney
2,481,608(7)
6.90%
Common
Stuart Sternberg
2,428,671(8)
6.76%
